These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 9917557
1. [Informative value of Hemoccult test according to the number of positive slides in mass screening of colorectal cancer]. Tazi MA, Faivre J, Lejeune C, Dassonville F, Benhamiche AM. Bull Cancer; 1998 Dec; 85(12):1055-9. PubMed ID: 9917557 [Abstract] [Full Text] [Related]
2. [Performance of the Hemoccult test in the screening of colorectal cancer and adenoma. Results of 5 screening campaigns in Saône-et-Loire]. Tazi MA, Faivre J, Lejeune C, Benhamiche AM, Dassonville F. Gastroenterol Clin Biol; 1999 May; 23(5):475-80. PubMed ID: 10429850 [Abstract] [Full Text] [Related]
3. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. Macrae FA, St John DJ. Gastroenterology; 1982 May; 82(5 Pt 1):891-8. PubMed ID: 7060910 [Abstract] [Full Text] [Related]
4. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Smith A, Young GP, Cole SR, Bampton P. Cancer; 2006 Nov 01; 107(9):2152-9. PubMed ID: 16998938 [Abstract] [Full Text] [Related]
5. Fecal occult blood testing: clinical value and limitations. Simon JB. Gastroenterologist; 1998 Mar 01; 6(1):66-78. PubMed ID: 9531118 [Abstract] [Full Text] [Related]
11. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV. J Natl Cancer Inst; 2007 Oct 03; 99(19):1462-70. PubMed ID: 17895475 [Abstract] [Full Text] [Related]
12. Experiences in providing a screening service for colorectal cancer from a pathology laboratory. Edwards JE, Williams JA, Thomas DW. Pathology; 2004 Aug 03; 36(4):330-4. PubMed ID: 15370132 [Abstract] [Full Text] [Related]
13. Population colorectal cancer screening with fecal occult blood test. Rennert G, Rennert HS, Miron E, Peterburg Y. Cancer Epidemiol Biomarkers Prev; 2001 Nov 03; 10(11):1165-8. PubMed ID: 11700264 [Abstract] [Full Text] [Related]
14. Colorectal cancer mass screening event utilising quantitative faecal occult blood test. Chew MH, Suzanah N, Ho KS, Lim JF, Ooi BS, Tang CL, Eu KW. Singapore Med J; 2009 Apr 03; 50(4):348-53. PubMed ID: 19421676 [Abstract] [Full Text] [Related]
15. Comparison of predictive value for colorectal cancer in subjects with and without rectal bleeding. Nakama H, Kayano T, Katsuura T, Kamigaito T, Shimada S, Nishikawa N, Yoshii S, Kamijo N. Hepatogastroenterology; 1999 Apr 03; 46(27):1730-2. PubMed ID: 10430332 [Abstract] [Full Text] [Related]
16. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT). Hoff G, Grotmol T, Thiis-Evensen E, Bretthauer M, Gondal G, Vatn MH. Gut; 2004 Sep 03; 53(9):1329-33. PubMed ID: 15306594 [Abstract] [Full Text] [Related]
17. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Kronborg O, Jørgensen OD, Fenger C, Rasmussen M. Scand J Gastroenterol; 2004 Sep 03; 39(9):846-51. PubMed ID: 15513382 [Abstract] [Full Text] [Related]
18. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer. Parente F, Marino B, DeVecchi N, Moretti R, Lecco Colorectal Cancer Screening Group, Ucci G, Tricomi P, Armellino A, Redaelli L, Bargiggia S, Cristofori E, Masala E, Tortorella F, Gattinoni A, Odinolfi F, Pirola ME. Br J Surg; 2009 May 03; 96(5):533-40. PubMed ID: 19358181 [Abstract] [Full Text] [Related]